目次

Table of Content

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Application Segment
1.1.1.2. Technology Segment
1.1.1.3. Modality Segment
1.1.1.4. End use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.3.1. Objectives
1.3.2. Objective - 1
1.3.3. Objective - 2
1.3.4. Objective - 3
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information or Data Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. List of Abbreviations

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Technology & Application Snapshot
2.3. Modality & End Use Snapshot
2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Worldwide increase in cancer prevalence
3.2.1.2. Advancements in imaging techniques and increasing affordability of diagnostics
3.2.1.3. Growth of personalized therapeutics and diagnostics
3.2.2. Market Restraint Analysis
3.2.2.1. High costs associated with R&D and clinical trials
3.2.2.2. Presence of non-valued based reimbursement policy
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis

Chapter 4. Technology Business Analysis
4.1. Tissue Diagnostics Market: Technology Movement Analysis
4.2. Immunohistochemistry
4.2.1. Immunohistochemistry Market, 2018 - 2030 (USD Million)
4.2.2. Instruments
4.2.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.2.2.2. Slide Staining Systems
4.2.2.2.1. Slide Staining Systems Market, 2018 - 2030 (USD Million)
4.2.2.3. Tissue Microarrays
4.2.2.3.1. Tissue Microarrays Market, 2018 - 2030 (USD Million)
4.2.2.4. Tissue Processing Systems
4.2.2.4.1. Tissue Processing Systems Market, 2018 - 2030 (USD Million)
4.2.2.5. Slide Scanners
4.2.2.5.1. Slide Scanners Market, 2018 - 2030 (USD Million)
4.2.2.6. Cell Processors
4.2.2.6.1. Cell Processors Market, 2018 - 2030 (USD Million)
4.2.2.7. Microtomes
4.2.2.7.1. Microtomes Market, 2018 - 2030 (USD Million)
4.2.2.8. Embedding Systems
4.2.2.8.1. Embedding Systems Market, 2018 - 2030 (USD Million)
4.2.2.9. Cover Slippers
4.2.2.9.1. Cover Slippers Market, 2018 - 2030 (USD Million)
4.2.2.10. Other Products
4.2.2.10.1. Other Products Market, 2018 - 2030 (USD Million)
4.2.3. Consumables
4.2.3.1. Consumables Market, 2018 - 2030 (USD Million)
4.2.3.2. H&E stainer coverslipper
4.2.3.2.1. H&E stainer coverslipper Market, 2018 - 2030 (USD Million)
4.2.3.3. IHC stainer coverslipper
4.2.3.3.1. IHC stainer coverslipper Market, 2018 - 2030 (USD Million)
4.2.3.4. Antibodies
4.2.3.4.1. Antibodies Market, 2018 - 2030 (USD Million)
4.2.3.5. Others
4.2.3.5.1. Others Market, 2018 - 2030 (USD Million)
4.3. In situ Hybridization
4.3.1. In situ Hybridization Market, 2018 - 2030 (USD Million)
4.3.2. Instruments
4.3.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.3.2.2. Stainers
4.3.2.2.1. Stainers Market, 2018 - 2030 (USD Million)
4.3.2.3. Others
4.3.2.3.1. Others Market, 2018 - 2030 (USD Million)
4.3.3. Consumables
4.3.3.1. Consumables Market, 2018 - 2030 (USD Million)
4.3.4. Software
4.3.4.1. Software Market, 2018 - 2030 (USD Million)
4.4. Primary & Special Staining
4.4.1. Primary & Special Staining Market, 2018 - 2030 (USD Million)
4.5. Digital Pathology & Workflow
4.5.1. Digital Pathology & Workflow Market, 2018 - 2030 (USD Million)
4.5.2. Image Analysis Informatics
4.5.2.1. Image Analysis Informatics Market, 2018 - 2030 (USD Million)
4.5.3. Information Management System Storage & Communication
4.5.3.1. Information Management System Storage & Communication Market, 2018 - 2030 (USD Million)
4.6. Anatomic Pathology
4.6.1. Anatomic Pathology Market, 2018 - 2030 (USD Million)
4.6.2. Instruments
4.6.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.6.2.2. Microtomes & Cryostat Microtomes
4.6.2.2.1. Microtomes & Cryostat Microtomes Market, 2018 - 2030 (USD Million)
4.6.2.3. Tissue Processors
4.6.2.3.1. Tissue Processors Market, 2018 - 2030 (USD Million)
4.6.2.4. Automatic Strainers
4.6.2.4.1. Automatic Strainers Market, 2018 - 2030 (USD Million)
4.6.2.5. Other Products
4.6.2.5.1. Other Products Market, 2018 - 2030 (USD Million)
4.6.3. Consumables
4.6.3.1. Consumables Market, 2018 - 2030 (USD Million)
4.6.3.2. Antibodies & Reagents
4.6.3.2.1. Antibodies & Reagents Market, 2018 - 2030 (USD Million)
4.6.3.3. Probes & Kits
4.6.3.3.1. Probes & Kits Market, 2018 - 2030 (USD Million)
4.6.3.4. Others
4.6.3.4.1. Others Market, 2018 - 2030 (USD Million)
4.7. Molecular Pathology
4.7.1. Anatomic Pathology Market, 2018 - 2030 (USD Million)
4.7.2. Instruments
4.7.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.7.3. Reagents
4.7.3.1. Reagents Market, 2018 - 2030 (USD Million)
4.7.3.2. Fluorescence Reagents
4.7.3.2.1. Fluorescence Reagents Market, 2018 - 2030 (USD Million)
4.7.3.3. Others
4.7.3.3.1. Others Market, 2018 - 2030 (USD Million)
4.7.4. Others
4.7.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis
5.1. Tissue Diagnostics Market: Application Movement Analysis
5.2. Breast Cancer
5.2.1. Breast Cancer Market, 2018 - 2030 (USD Million)
5.3. Non-Small Cell Lung Cancer
5.3.1. Non-Small Cell Lung Cancer Market, 2018 - 2030 (USD Million)
5.4. Prostate Cancer
5.4.1. Prostate Cancer Market, 2018 - 2030 (USD Million)
5.5. Gastric Cancer
5.5.1. Gastric Cancer Market, 2018 - 2030 (USD Million)
5.6. Other Cancers
5.6.1. Other Cancers Technology Market, 2018 - 2030 (USD Million)

Chapter 6. Modality Business Analysis
6.1. Tissue Diagnostics Market: Modality Movement Analysis
6.2. Clinical
6.2.1. Clinical Market, 2018 - 2030 (USD Million)
6.3. Pharma / CRO / Research market
6.3.1. Pharma / CRO / Research Market, 2018 - 2030 (USD Million)

Chapter 7. End Use Business Analysis
7.1. Hospitals
7.1.1. Hospitals Market, 2018 - 2030 (USD Million)
7.2. Diagnostic Center
7.2.1. Diagnostic Center Market, 2018 - 2030 (USD Million)
7.3. Pharmaceutical Organizations
7.3.1. Pharmaceutical Organizations Market, 2018 - 2030 (USD Million)
7.4. CRO
7.4.1. CRO Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis
8.1. Tissue Diagnostics Market Share By Region, 2024 & 2030
8.2. North America
8.2.1. SWOT Analysis
8.2.2. North America Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.2.3. U.S.
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Regulatory Framework
8.2.3.5. U.S. Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Key Country Dynamics
8.2.4.2. Target Disease Prevalence
8.2.4.3. Competitive Scenario
8.2.4.4. Regulatory Framework
8.2.4.5. Mexico Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.2.5. Canada
8.2.5.1. Key Country Dynamics
8.2.5.2. Target Disease Prevalence
8.2.5.3. Competitive Scenario
8.2.5.4. Regulatory Framework
8.2.5.5. Canada Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. SWOT Analysis
8.3.2. Europe Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.3.3. UK
8.3.3.1. Key Country Dynamics
8.3.3.2. Target Disease Prevalence
8.3.3.3. Competitive Scenario
8.3.3.4. Regulatory Framework
8.3.3.5. UK Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.3.4. Germany
8.3.4.1. Key Country Dynamics
8.3.4.2. Target Disease Prevalence
8.3.4.3. Competitive Scenario
8.3.4.4. Regulatory Framework
8.3.4.5. Germany Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.3.5. Spain
8.3.5.1. Key Country Dynamics
8.3.5.2. Target Disease Prevalence
8.3.5.3. Competitive Scenario
8.3.5.4. Regulatory Framework
8.3.5.5. Spain Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.3.6. France
8.3.6.1. Key Country Dynamics
8.3.6.2. Target Disease Prevalence
8.3.6.3. Competitive Scenario
8.3.6.4. Regulatory Framework
8.3.6.5. France Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.3.7. Italy
8.3.7.1. Key Country Dynamics
8.3.7.2. Target Disease Prevalence
8.3.7.3. Competitive Scenario
8.3.7.4. Regulatory Framework
8.3.7.5. Italy Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.3.8. Denmark
8.3.8.1. Key Country Dynamics
8.3.8.2. Target Disease Prevalence
8.3.8.3. Competitive Scenario
8.3.8.4. Regulatory Framework
8.3.8.5. Denmark Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.3.9. Sweden
8.3.9.1. Key Country Dynamics
8.3.9.2. Target Disease Prevalence
8.3.9.3. Competitive Scenario
8.3.9.4. Regulatory Framework
8.3.9.5. Sweden Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.3.10. Norway
8.3.10.1. Key Country Dynamics
8.3.10.2. Target Disease Prevalence
8.3.10.3. Competitive Scenario
8.3.10.4. Regulatory Framework
8.3.10.5. Norway Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. SWOT Analysis
8.4.2. Asia Pacific Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.4.3. Japan
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Competitive Scenario
8.4.3.4. Regulatory Framework
8.4.3.5. Japan Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.4.4. China
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Competitive Scenario
8.4.4.4. Regulatory Framework
8.4.4.5. China Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.4.5. India
8.4.5.1. Key Country Dynamics
8.4.5.2. Target Disease Prevalence
8.4.5.3. Competitive Scenario
8.4.5.4. Regulatory Framework
8.4.5.5. India Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.4.6. South Korea
8.4.6.1. Key Country Dynamics
8.4.6.2. Target Disease Prevalence
8.4.6.3. Competitive Scenario
8.4.6.4. Regulatory Framework
8.4.6.5. South Korea Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.4.7. Australia
8.4.7.1. Key Country Dynamics
8.4.7.2. Target Disease Prevalence
8.4.7.3. Competitive Scenario
8.4.7.4. Regulatory Framework
8.4.7.5. Australia Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.4.8. Thailand
8.4.8.1. Key Country Dynamics
8.4.8.2. Target Disease Prevalence
8.4.8.3. Competitive Scenario
8.4.8.4. Regulatory Framework
8.4.8.5. Thailand Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. SWOT Analysis
8.5.2. Latin America Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.5.3. Brazil
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Competitive Scenario
8.5.3.4. Regulatory Framework
8.5.3.5. Brazil Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Target Disease Prevalence
8.5.4.3. Competitive Scenario
8.5.4.4. Regulatory Framework
8.5.4.5. Argentina Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.6. MEA
8.6.1. SWOT Analysis
8.6.2. MEA Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.6.3. South Africa
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Competitive Scenario
8.6.3.4. Regulatory Framework
8.6.3.5. South Africa Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Competitive Scenario
8.6.4.4. Regulatory Framework
8.6.4.5. UAE Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.6.5. Saudi Arabia
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Competitive Scenario
8.6.5.4. Regulatory Framework
8.6.5.5. Saudi Arabia Tissue Diagnostics Market, 2018 - 2030 (USD Million)
8.6.6. Kuwait
8.6.6.1. Key Country Dynamics
8.6.6.2. Target Disease Prevalence
8.6.6.3. Competitive Scenario
8.6.6.4. Regulatory Framework
8.6.6.5. Kuwait Tissue Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2022
9.4. Company Profiles/Listing
9.4.1. F. Hoffmann-La Roche Ltd.
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Technology Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Abbott Laboratories
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Technology Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Thermo Fisher Scientific, Inc.
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Technology Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Siemens
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Technology Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Danaher Corporation
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Technology Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. bioMerieux SA
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Technology Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. QIAGEN
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Technology Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. BD
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Technology Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Merck KGaA
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Technology Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. GE Healthcare
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Technology Benchmarking
9.4.10.4. Strategic Initiatives
9.4.11. BioGenex
9.4.11.1. Overview
9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.11.3. Technology Benchmarking
9.4.11.4. Strategic Initiatives
9.4.12. Cell Signaling Technology, Inc.
9.4.12.1. Overview
9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.12.3. Technology Benchmarking
9.4.12.4. Strategic Initiatives
9.4.13. Bio SB
9.4.13.1. Overview
9.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.13.3. Technology Benchmarking
9.4.13.4. Strategic Initiatives
9.4.14. DiaGenic ASA
9.4.14.1. Overview
9.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.14.3. Technology Benchmarking
9.4.14.4. Strategic Initiatives
9.4.15. Agilent Technologies, Inc
9.4.15.1. Overview
9.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.15.3. Technology Benchmarking
9.4.15.4. Strategic Initiatives

List of Tables
Table 1 List of abbreviation
Table 2 Global tissue diagnostics market, by region, 2018 - 2030 (USD Billion)
Table 3 Global tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 4 Global tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 5 Global tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 6 Global tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 7 North America tissue diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 8 North America tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 9 North America tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 10 North America tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 11 North America tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 12 U.S. tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 13 U.S. tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 14 U.S. tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 15 U.S. tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 16 Canada tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 17 Canada tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 18 Canada tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 19 Canada tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 20 Mexico tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 21 Mexico tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 22 Mexico tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 23 Mexico tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 24 Europe tissue diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 25 Europe tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 26 Europe tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 27 Europe tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 28 Europe tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 29 UK tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 30 UK tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 31 UK tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 32 UK tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 33 Germany tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 34 Germany tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 35 Germany tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 36 Germany tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 37 France tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 38 France tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 39 France tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 40 France tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 41 Italy tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 42 Italy tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 43 Italy tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 44 Italy tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 45 Spain tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 46 Spain tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 47 Spain tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 48 Spain tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 49 Denmark tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 50 Denmark tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 51 Denmark tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 52 Denmark tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 53 Sweden tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 54 Sweden tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 55 Sweden tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 56 Sweden tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 57 Norway tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 58 Norway tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 59 Norway tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 60 Norway tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 61 Asia Pacific tissue diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 62 Asia Pacific tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 63 Asia Pacific tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 64 Asia Pacific tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 65 Asia Pacific tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 66 Japan tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 67 Japan tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 68 Japan tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 69 Japan tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 70 China tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 71 China tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 72 China tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 73 China tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 74 India tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 75 India tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 76 India tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 77 India tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 78 Australia tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 79 Australia tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 80 Australia tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 81 Australia tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 82 South Korea tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 83 South Korea tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 84 South Korea tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 85 South Korea tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 86 Thailand tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 87 Thailand tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 88 Thailand tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 89 Thailand tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 90 Latin America tissue diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 91 Latin America tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 92 Latin America tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 93 Latin America tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 94 Latin America tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 95 Brazil tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 96 Brazil tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 97 Brazil tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 98 Brazil tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 99 Argentina tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 100 Argentina tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 101 Argentina tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 102 Argentina tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 103 MEA tissue diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 104 MEA tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 105 MEA tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 106 MEA tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 107 MEA tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 108 South Africa tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 109 South Africa tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 110 South Africa tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 111 South Africa tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 112 Saudi Arabia tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 113 Saudi Arabia tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 114 Saudi Arabia tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 115 Saudi Arabia tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 116 UAE tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 117 UAE tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 118 UAE tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 119 UAE tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
Table 120 Kuwait tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 121 Kuwait tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
Table 122 Kuwait tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 123 Kuwait tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)

List of Figures
Fig. 1 Tissue diagnostics testing market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Technology and end use snapshot
Fig. 11 Application and modality Segment snapshot
Fig. 12 Competitive landscape snapshot
Fig. 13 In Vitro Diagnostics (IVD) market value, 2023 (USD billion)
Fig. 14 Market trends & outlook
Fig. 15 Incidence of most common cancers globally, 2022
Fig. 16 Incidence of most common cancers region wise, 2022
Fig. 17 FDA approved Companion Diagnostic (CDx) assays as of 2020
Fig. 18 Consultant workforce retiring in the next 5 years across all specialties, 2021-2024
Fig. 19 Porter’s five force analysis
Fig. 20 PESTEL analysis
Fig. 21 Tissue diagnostics market: Technology outlook and key takeaways
Fig. 22 Tissue diagnostics market: Technology movement analysis
Fig. 23 Immunohistochemistry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Slide staining system market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Tissue microarrays market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Tissue processing systems market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Slide scanners market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Cell processors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Microtomes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Embedding systems market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Cover slippers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Other products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 H&E stainer coverslipper market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 IHC stainer coverslipper market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Antibodies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Other IHC reagents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Software market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 In situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Stainers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Software market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Primary & special staining market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Digital pathology and workflow market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Image analysis informatics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Information management system storage & communication market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Anatomic pathology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Microtomes & cryostat microtomes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Tissue processors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Automatic strainers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Microscopes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Other products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Reagents & antibodies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Probes & kits market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Molecular pathology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Fluorescence reagents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Tissue diagnostics market: Application outlook and key takeaways
Fig. 68 Tissue diagnostics market: Application movement analysis
Fig. 69 Breast cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Non-small cell lung cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Prostate cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Gastric cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Other cancers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Tissue diagnostics market: End Use outlook and key takeaways
Fig. 75 Tissue diagnostics market: End Use movement analysis
Fig. 76 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Diagnostic center market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Pharmaceutical organizations market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 CRO market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Tissue diagnostics market: Modality outlook and key takeaways
Fig. 81 Tissue diagnostics market: Modality movement analysis
Fig. 82 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Pharma/CRO/Research market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Tissue diagnostics market revenue, by region, 2023 & 2030 (USD Million)
Fig. 85 Regional marketplace: Key takeaways
Fig. 86 Regional marketplace: Key takeaways
Fig. 87 North America tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 U.S. tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 Canada tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Mexico tissue diagnostics market estimates and forecast, 2018-2030 (USD Million)
Fig. 94 Europe tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 UK tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 Germany Tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 99 Key country dynamics
Fig. 100 France tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 101 Key country dynamics
Fig. 102 Spain tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 103 Key country dynamics
Fig. 104 Italy Tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 105 Key country dynamics
Fig. 106 Denmark tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 Sweden tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 109 Key country dynamics
Fig. 110 Norway tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 111 Rest of Europe tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 112 Asia Pacific tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 113 Key country dynamics
Fig. 114 Japan tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 115 Key country dynamics
Fig. 116 China tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 117 Key country dynamics
Fig. 118 India tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 119 Key country dynamics
Fig. 120 Australia tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 121 Key country dynamics
Fig. 122 Thailand tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 123 Key country dynamics
Fig. 124 South Korea tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 125 Rest of Asia Pacific tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 126 Latin America tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 127 Key country dynamics
Fig. 128 Brazil tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 129 Key country dynamics
Fig. 130 Argentina tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 131 Rest of Latin America tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 132 MEA tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 133 Key country dynamics
Fig. 134 South Africa tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 135 Key country dynamics
Fig. 136 Saudi Arabia tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 137 Key country dynamics
Fig. 138 UAE tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 139 Key country dynamics
Fig. 140 Kuwait tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 141 Rest of MEA tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 142 Key company categorization
Fig. 143 Company market share analysis, 2023
Fig. 144 Strategic framework